The content on this site is intended for health professionals.
 |
ISSN: 3006-4090 EISSN: 3006-4104
Health Research in Africa (HRA) is an open-access, monthly, peer-reviewed, multidisciplinary medical journal published by Afrimvoe Medical Services, Yaoundé, Cameroon. HRA is partnered with Health Sciences and Disease, the official publication of the Faculty of Medicine and Biomedical Sciences (FMBS) of the University of Yaoundé I.
Our Mission
To fill critical gaps in health data from Africa and other low- and middle-income countries (LMICs) worldwide, by publishing high-quality, actionable research that can improve clinical practice, health policy, and public health outcomes.
Our Scope
HRA covers all aspects of medicine, pharmacy, biomedical and health sciences, including health technologies, public health, and societal issues. We prioritize applied research with demonstrated or potential impact on health in resource-constrained settings.
Geographic Inclusivity
While HRA's name reflects our primary focus on Africa, we welcome submissions from all regions of the world, provided the research addresses health priorities relevant to LMICs. We believe that scientific knowledge is universal and that cross-regional collaboration strengthens the global health community.
Our Values
- Excellence: We uphold the highest standards of editorial and scientific quality.
- Integrity: We adhere to the ethical principles of the ICMJE, WAME, COPE, and CSE.
- Relevance: We prioritize research that addresses the most pressing health challenges in low-resource settings.
- Collaboration: We foster partnerships with authors, reviewers, and institutions worldwide.
- Open Access: We believe in the free and unrestricted dissemination of scientific knowledge.
Indexing
HRA is indexed in Scopus and other major databases
Please, download the print version of "About Health Research in Africa."
Health Research in Africa a le plaisir d’annoncer la parution de l’ouvrage : « La pharmacologie médicale : sa naissance, ses fondamentaux, ses contours actuels, son futur », du Pr E. Eben-Moussi.
Read more about Vient de paraître : Une somme magistrale sur la Pharmacologie Médicale
Afrimvoe Medical Services
Carrefour Station Ola. Nouvelle Route Nkolbisson (N3)
P.O Box 17583 Yaounde - Cameroon
HRA editorial team is lead by Pr Nko'o Amvene Samuel. Please, click here to see the whole team.
The paper may have been published in our partner journal. Please, check on HSD website.
To get the off-print of the whole publication, please click on "pdf" below the title.
Conseil Africain et Malgache pour l’Enseignement Supérieur (CAMES)
HRA’s Publications Policy Committee follows the recommendations of the International Committee of Medical Journal Editors (ICMJE), the World Association of Medical Editors (WAME), the Council of Science Editors (CSE) and the Committee on Publication Ethics (COPE) for guidance on policies and procedures related to publication ethics. The policies for HRA have been adapted from those three advisory bodies and, where necessary, modified and tailored to meet the specific content, audiences, and aims of HRA.
HRA is published monthly since 2024.
By default, articles published by HRA are Open Access and distributed under the terms of the Creative Commons Non-Commercial No-Derivatives License (CC BY-NC-ND 4.0). This license enables reusers to copy and distribute the material in any medium or format in unadapted form only, for noncommercial purposes only, and only so long as attribution is given to the creator. CC BY-NC-ND includes the following elements:
The authors publishing under the Creative Commons Non-Commercial No-Derivatives License (CC BY-NC-ND 4.0). with HRA retain all rights, which means that the authors can read, print, and download, redistribute or republish (eg, display in a repository), translate the article (for private use only, not for distribution), download for text and data mining, reuse portions or extracts in other works, but they are not allowed to sell or re-use for commercial purposes, without asking prior permission from the publisher, provided the original work is properly cited.
Research manuscripts are initially checked by the EIC or section editors for identification of gross deficiencies. At this stage, the proposal may be rejected. After this initial screening, articles (with supplementary material ) are made available to one or two-reviewers whose names are hidden from the author and whose review is guided by a checklist (single anonymized review) (https://b.link/peer-review. Author recommended reviewers are not allowed. The review summary is signed by the reviewer and is not posted with article. The review process may take days to weeks to reach a final decision that is the responsibility of the EIC. The duration from submission to publication may take one to six months (average: 6 months). So, the authors should avoid contacting the editorial office less than 6 weeks after the initial submission. The date of publication is published in the paper as well as dates of submission and acceptance.
Article submission is free of charges, but if your paper is accepted for publication, you will be asked to pay article processing charges (APC) to cover publications costs, depending on the type, complexity and length of the work, and on the number of authors. The minimum amount of APC is about 250 euros or 300 dollars or 150 000 XAF. If an author from a low revenue country does not have enough funds to pay such fees and the publication is a really worthy work, he may have an opportunity to partially waive each fee by asking the EIC.. APC are due before the accepted paper is published. Inquiries about fast track, manuscript status and preparation, as well as letters to the editor, should be directed to the Editor in Chief
